3 studies found for: Eculizumab for Neuromyelitis Optica Spectrum Disorder
|1||Enrolling by invitation||
An Open Label Extension Trial of Eculizumab in Relapsing NMO Patients
A Double Blind Trial To Evaluate The Safety And Efficacy Of Eculizumab In Relapsing NMO Patients (PREVENT Study)
An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica
† Study has passed its completion date and status has not been verified in more than two years.